๐ŸŽ—๏ธ OncologyCapsule

    Nilotinib

    Nilotinib

    A BCR-ABL tyrosine kinase inhibitor used to treat Philadelphia chromosome-positive chronic myeloid leukemia in newly diagnosed patients or those resistant to or intolerant of imatinib.

    Form

    Capsule

    Uses

    2

    Side effects

    6

    Category

    Oncology

    01

    What is Nilotinib used for?

    • Treatment of newly diagnosed Ph+ CML in chronic phase
    • Treatment of chronic or accelerated phase Ph+ CML resistant to or intolerant of prior imatinib therapy
    02

    Nilotinib side effects

    The following side effects have been reported for Nilotinib. Their order does not indicate how often an effect occurs.

    Myelosuppression
    QT prolongation
    Rash
    Nausea
    Headache
    Elevated liver enzymes
    03

    Nilotinib warnings & precautions

    • Prolongs QT interval; sudden deaths have been reported
    • Obtain baseline ECG and monitor periodically; correct hypokalemia and hypomagnesemia before treatment

    Loading FDA dataโ€ฆ

    04

    Frequently asked questions

    05

    Related medications

    Share

    Share this drug info.

    Help friends and family understand Nilotinib in plain language.

    Disclaimer: This information is sourced from the FDA openFDA database and is provided for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before starting or changing medication.